Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Psychiatrists' self-reported adherence to evidence-based prescribing practices in the treatment of schizophrenia.

Young GJ, Mohr DC, Meterko M, Seibert MN, McGlynn G.

Psychiatr Serv. 2006 Jan;57(1):130-2.

PMID:
16399975
2.

[Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].

Jalenques I, Ortega V, Legrand G, Auclair C.

Encephale. 2016 Apr;42(2):124-9. doi: 10.1016/j.encep.2015.05.004. Epub 2016 Jan 12. French.

PMID:
26796558
3.

Psychiatrists' attitudes to maintenance medication for patients with schizophrenia.

Patel MX, Nikolaou V, David AS.

Psychol Med. 2003 Jan;33(1):83-9.

PMID:
12537039
4.

Psychiatrists' awareness of partial- and non-adherence to antipsychotic medication in schizophrenia: results from the Australian ADHES survey.

Kulkarni J, Reeve-Parker K.

Australas Psychiatry. 2015 Jun;23(3):258-64. doi: 10.1177/1039856215576396. Epub 2015 Mar 17.

PMID:
25783668
5.

[Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].

Bret P, Bret MC, Queuille E.

Encephale. 2009 Apr;35(2):129-38. doi: 10.1016/j.encep.2008.03.007. Epub 2008 Jul 7. French.

PMID:
19393381
6.

Medical decision making in antipsychotic drug choice for schizophrenia.

Hamann J, Langer B, Leucht S, Busch R, Kissling W.

Am J Psychiatry. 2004 Jul;161(7):1301-4.

PMID:
15229068
7.

Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns.

Apiquian R, Fresán A, de la Fuente-Sandoval C, Ulloa RE, Nicolini H.

BMC Psychiatry. 2004 Apr 27;4:12.

8.

Survey of medication adherence in patients with schizophrenia--Korean ADHES data.

Kim SW, Yoon JS, Choi SK.

Hum Psychopharmacol. 2006 Dec;21(8):533-7.

PMID:
17133616
9.

Self-reported prescribing practices for schizophrenic patients among Israeli psychiatrists.

Heresco-Levy U, Brom D, Greenberg D.

Isr J Psychiatry Relat Sci. 1993;30(3):164-74.

PMID:
7901179
10.

Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.

Tang Y, Chang CC, Lave JR, Gellad WF, Huskamp HA, Donohue JM.

J Ment Health Policy Econ. 2016 Mar;19(1):45-59.

11.

Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.

Loosbrock DL, Zhao Z, Johnstone BM, Morris LS.

J Ment Health Policy Econ. 2003 Jun;6(2):67-75.

PMID:
14578539
12.

Child and adolescent psychiatrists' attitudes and practices prescribing second generation antipsychotics.

Rodday AM, Parsons SK, Correll CU, Robb AS, Zima BT, Saunders TS, Leslie LK.

J Child Adolesc Psychopharmacol. 2014 Mar;24(2):90-3. doi: 10.1089/cap.2013.0133.

13.

Psychiatrists' psychotropic drug prescription preferences for themselves or their family members.

Latas M, Stojkovic T, Ralic T, Milovanovic S, Jasovic-Gasic M.

Psychiatr Danub. 2012 Jun;24(2):182-7.

14.

Psychiatric opinion and antipsychotic selection in the management of schizophrenia.

Arbuckle MR, Gameroff MJ, Marcus SC, West JC, Wilk J, Olfson M.

Psychiatr Serv. 2008 May;59(5):561-5. doi: 10.1176/ps.2008.59.5.561.

PMID:
18451017
15.

Best practices: An initiative to curtail the use of antipsychotic polypharmacy in a state psychiatric hospital.

Patrick V, Schleifer SJ, Nurenberg JR, Gill KJ.

Psychiatr Serv. 2006 Jan;57(1):21-3.

PMID:
16399958
16.

Importance of open access to atypical antipsychotics for the treatment of schizophrenia and bipolar disorder: a European perspective.

Altamura AC, Armadoros D, Jaeger M, Kernish R, Locklear J, Volz HP.

Curr Med Res Opin. 2008 Aug;24(8):2271-82. doi: 10.1185/03007990802250056. Epub 2008 Jun 26.

PMID:
18588748
17.

Antipsychotic prescribing: do conflict of interest policies make a difference?

Anderson TS, Huskamp HA, Epstein AJ, Barry CL, Men A, Berndt ER, Horvitz-Lennon M, Normand SL, Donohue JM.

Med Care. 2015 Apr;53(4):338-45. doi: 10.1097/MLR.0000000000000329.

18.

Psychiatrists' attitude to antipsychotic depot treatment in patients with first-episode schizophrenia.

Heres S, Reichhart T, Hamann J, Mendel R, Leucht S, Kissling W.

Eur Psychiatry. 2011 Jul-Aug;26(5):297-301. doi: 10.1016/j.eurpsy.2009.12.020. Epub 2010 Jun 8.

PMID:
20570493
20.

Adding or switching antipsychotic medications in treatment-refractory schizophrenia.

Kreyenbuhl J, Marcus SC, West JC, Wilk J, Olfson M.

Psychiatr Serv. 2007 Jul;58(7):983-90.

Supplemental Content

Support Center